Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development.

Han JA, Kang YJ, Shin C, Ra JS, Shin HH, Hong SY, Do Y, Kang S.

Nanomedicine. 2014 Apr;10(3):561-9. doi: 10.1016/j.nano.2013.11.003. Epub 2013 Nov 18.

PMID:
24262997
[PubMed - indexed for MEDLINE]
2.

Lumazine synthase protein cage nanoparticles as antigen delivery nanoplatforms for dendritic cell-based vaccine development.

Ra JS, Shin HH, Kang S, Do Y.

Clin Exp Vaccine Res. 2014 Jul;3(2):227-34. doi: 10.7774/cevr.2014.3.2.227. Epub 2014 Jun 20.

PMID:
25003097
[PubMed]
Free PMC Article
3.

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.

Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F.

Cancer Immunol Immunother. 2004 Nov;53(11):963-77. Epub 2004 May 14.

PMID:
15146294
[PubMed - indexed for MEDLINE]
4.

ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.

Duewell P, Kisser U, Heckelsmiller K, Hoves S, Stoitzner P, Koernig S, Morelli AB, Clausen BE, Dauer M, Eigler A, Anz D, Bourquin C, Maraskovsky E, Endres S, Schnurr M.

J Immunol. 2011 Jul 1;187(1):55-63. doi: 10.4049/jimmunol.1004114. Epub 2011 May 25.

PMID:
21613613
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.

Hamdy S, Elamanchili P, Alshamsan A, Molavi O, Satou T, Samuel J.

J Biomed Mater Res A. 2007 Jun 1;81(3):652-62.

PMID:
17187395
[PubMed - indexed for MEDLINE]
6.

CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.

Ankathatti Munegowda M, Xu S, Freywald A, Xiang J.

Mol Immunol. 2012 Jun;51(2):143-9. doi: 10.1016/j.molimm.2012.02.120. Epub 2012 Mar 17.

PMID:
22424785
[PubMed - indexed for MEDLINE]
7.

Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.

Hennies CM, Reboulet RA, Garcia Z, Nierkens S, Wolkers MC, Janssen EM.

Clin Exp Immunol. 2011 Mar;163(3):381-91. doi: 10.1111/j.1365-2249.2010.04305.x. Epub 2011 Jan 14.

PMID:
21235535
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming.

Schlecht G, Loucka J, Najar H, Sebo P, Leclerc C.

J Immunol. 2004 Nov 15;173(10):6089-97.

PMID:
15528345
[PubMed - indexed for MEDLINE]
Free Article
9.

H2-M3-restricted CD8+ T cells augment CD4+ T-cell responses by promoting DC maturation.

Chow MT, Teh HS.

Eur J Immunol. 2010 May;40(5):1408-17. doi: 10.1002/eji.200939934.

PMID:
20162552
[PubMed - indexed for MEDLINE]
10.

Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.

De Smedt T, Smith J, Baum P, Fanslow W, Butz E, Maliszewski C.

J Immunol. 2002 Jan 15;168(2):661-70.

PMID:
11777959
[PubMed - indexed for MEDLINE]
Free Article
11.

Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A.

Joffre OP, Sancho D, Zelenay S, Keller AM, Reis e Sousa C.

Eur J Immunol. 2010 May;40(5):1255-65. doi: 10.1002/eji.201040419.

PMID:
20333625
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity.

Wells JW, Cowled CJ, Darling D, Guinn BA, Farzaneh F, Noble A, Galea-Lauri J.

Cancer Immunol Immunother. 2007 Dec;56(12):1861-73. Epub 2007 May 9.

PMID:
17487489
[PubMed - indexed for MEDLINE]
13.

"Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.

Elamanchili P, Lutsiak CM, Hamdy S, Diwan M, Samuel J.

J Immunother. 2007 May-Jun;30(4):378-95.

PMID:
17457213
[PubMed - indexed for MEDLINE]
14.

The role of the e3 ligase cbl-B in murine dendritic cells.

Wallner S, Lutz-Nicoladoni C, Tripp CH, Gastl G, Baier G, Penninger JM, Stoitzner P, Wolf D.

PLoS One. 2013 Jun 6;8(6):e65178. doi: 10.1371/journal.pone.0065178. Print 2013.

PMID:
23762309
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation.

Thomas MJ, Noble A, Sawicka E, Askenase PW, Kemeny DM.

J Immunol. 2002 Jan 1;168(1):216-23.

PMID:
11751965
[PubMed - indexed for MEDLINE]
Free Article
16.

Efficient cross-presentation of soluble exogenous antigens introduced into dendritic cells using a weak-based amphiphilic peptide.

Ikeuchi N, Futami J, Hosoi A, Noji S, Kurachi M, Ueha S, Fujii S, Yamada H, Matsushima K, Moriyasu F, Kakimi K.

Biochem Biophys Res Commun. 2010 Feb 5;392(2):217-22. doi: 10.1016/j.bbrc.2010.01.019. Epub 2010 Jan 11.

PMID:
20067764
[PubMed - indexed for MEDLINE]
17.

Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation.

Hirosue S, Kourtis IC, van der Vlies AJ, Hubbell JA, Swartz MA.

Vaccine. 2010 Nov 23;28(50):7897-906. doi: 10.1016/j.vaccine.2010.09.077. Epub 2010 Oct 8.

PMID:
20934457
[PubMed - indexed for MEDLINE]
18.

Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.

Mitsui H, Okamoto T, Kanzaki M, Inozume T, Shibagaki N, Shimada S.

Br J Dermatol. 2010 Jan;162(1):29-41. doi: 10.1111/j.1365-2133.2009.09490.x. Epub 2009 Oct 26.

PMID:
19863514
[PubMed - indexed for MEDLINE]
19.
20.

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V.

J Immunol. 2003 Nov 15;171(10):5140-7.

PMID:
14607913
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk